Divis Laboratories Ltd | DIVI - Operating Expenses



Divis Laboratories Ltd reported 17.93B in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Alaunos Therapeutics USD 759K 391K Dec/2024
Aurobindo Pharma INR 70.35B 2.65B Mar/2025
Avita Medical AUD 28.36M 2.44M Dec/2024
Dianthus Therapeutics USD 35.12M 1.88M Jun/2025
Divis Laboratories Ltd 17.93B 130M Jun/2025
Ionis Pharmaceuticals USD 312.21M 34.21M Jun/2025
IQVIA Holdings USD 3.46B 124M Jun/2025
Lupin INR 49.26B 1.58B Jun/2025
Moderna USD 1.04B 113M Jun/2025
Organon & Co USD 1.27B 144M Jun/2025
Revvity USD 629.52M 36.99M Jun/2025
Tectonic Therapeutic USD 22.33M 8.34M Jun/2025
Tilray USD 253.17M 16.55M Nov/2024
Viatris USD 3.4B 2.88B Jun/2025
Xeris Pharmaceuticals USD 67.06M 8.64M Jun/2025